Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-23-008938
Filing Date
2023-04-03
Accepted
2023-04-03 06:01:40
Documents
3
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A mbrx20221129_pre14a.htm PRE 14A 633747
2 pcard01.jpg GRAPHIC 158017
3 pcard02.jpg GRAPHIC 92374
  Complete submission text file 0001437749-23-008938.txt   979800
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37758 | Film No.: 23790263
SIC: 2834 Pharmaceutical Preparations